A study has discovered the first genetic marker that can distinguish between aggressive versus benign bone tumors.
Browsing: Taxonomy > Genetics
The prostate cancer test combines genetic variations linked to prostate cancer and identifies the 1% of men that are at high risk.
In a medical breakthrough, a new approach to immunotherapy has led to complete regression of breast cancer in a patient unresponsive to all other treatments.
A genomic study has demonstrated that individuals with tumors that have high-microsatellite instability (MSI-H) are more likely to have Lynch syndrome.
Researchers have discovered first leukemia protective gene that is specific to the male-only Y chromosome.
Advanced triple-negative breast cancer patients who have inherited a BRCA mutation are twice as likely to benefit from carboplatin as docetaxel, a novel study suggests.
A study led by researchers at The Institute of Cancer Research (London, UK) has uncovered numerous ways of targeting prostate cancer.
In a landmark genetics study, a multi-institutional group of researchers have uncovered three distinct evolutionary paths for kidney cancer, allowing them to determine whether a tumor will be aggressive.
In the first-of-its-kind study, researchers have unearthed the unique genetic fingerprints of every bowel tumor and bowel cancer cell.
Green light from NICE for NSCLC immunotherapy; Pan-Cancer Atlas data and 40 myeloma genes unearthed.